Sacubitril/valsartan: um importante avanço no puzzle terapêutico da insuficiência cardíaca

Sacubitril/valsartan: um importante avanço no puzzle terapêutico da insuficiência cardíaca

Resumo: O sacubitril/valsartan (LCZ696) é um complexo supramolecular de sal de sódio do pró‐fármaco sacubitril, inibidor da neprilisina, e do valsartan, um antagonista dos recetores da angiotensina (ARB), administrado por via oral, recentemente aprovado no tratamento da insuficiência crónica (classe...

Full description

Bibliographic Details
Main Authors:	Pedro Marques da Silva, Carlos Aguiar
Format:	Article
Language:	English
Published:	Elsevier 2017-09-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255116303377

Similar Items

Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure
by: Pedro Marques da Silva, et al.
Published: (2017-09-01)

Experiencia con sacubitril/valsartán en una clínica de falla cardiaca
by: Maria P. Morales-Parra, et al.
Published: (2020-01-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
by: Luís Beck-da-Silva, et al.

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Insuficiencia cardiaca: una causa importante de muerte
by: Caridad de Dios Soler Morejón, et al.

Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
by: António Valentim Gonçalves, et al.
Published: (2019-06-01)

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
by: Ulrik Ø Andersen, et al.
Published: (2020-05-01)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018-08-01)

A narrative review on sacubitril/valsartan and ventricular arrhythmias
by: Gao, M., et al.
Published: (2022)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
by: Giuseppe Vergaro, et al.
Published: (2021-02-01)

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
by: Carlos Escobar, et al.
Published: (2019-12-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
by: Jelena P. Seferovic, et al.
Published: (2020-12-01)

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
by: Borja Quiroga, et al.
Published: (2019-11-01)

Sacubitril-valsartan in the real world: From theory to clinical practice
by: Ricardo Fontes-Carvalho
Published: (2018-06-01)

Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
by: Ramesh R. Dargad, et al.
Published: (2018-07-01)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
by: Prashanth Rawla, et al.
Published: (2019-05-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

12. Sacubitril/valsartan in the treatment of systemic right ventricular failure
by: Marieke Nederend, et al.
Published: (2021-02-01)

Renal protective effect of sacubitril/valsartan in patients with heart failure
by: Hui-Ling Hsieh, et al.
Published: (2021-02-01)

Avanços importantes
by: Cassilda Teixeira de Carvalho
Published: (2011-12-01)

Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants
by: Michael Fu, et al.
Published: (2020-12-01)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
by: Marcely Gimenes Bonatto, et al.
Published: (2020-06-01)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
by: Cuthbert JJ, et al.
Published: (2020-08-01)

Sacubitril/Valsartan for Heart Failure: Exciting Times but Are Doctors Informed and Ready?
by: Prithwish Banerjee
Published: (2017-01-01)

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
by: Yandrapalli S, et al.
Published: (2017-10-01)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01)

Data on effect of Sacubitril/valsartan on cardiac Remodelling in diabetic Cardiomyopathy rats
by: Jiao Ai, et al.
Published: (2021-04-01)

Exploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
by: Ashley L. Eadie, et al.
Published: (2021-05-01)

Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty
by: Francesco Cacciatore, et al.
Published: (2020-04-01)

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
by: Pema Raj, et al.
Published: (2021-08-01)

Editorial: avanços importantes
by: Cassilda Teixeira de Carvalho
Published: (2012-03-01)

Avanços no suporte circulatório mecânico no tratamento da insuficiência cardíaca
by: Claudio Leo Gelape, et al.
Published: (2012-02-01)

Manejo terapéutico actual de la insuficiencia cardíaca
by: Sarah María Regueira Betancourt, et al.
Published: (2014-10-01)

Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts
by: Xiaofei Li, et al.
Published: (2021-08-01)